IDEAYA Closes IPO, Full Exercise of Underwriters’ Option

IDEAYA Biosciences, Inc.(Nasdaq:IDYA) today announced the closing of its initial public offering of 5,750,000 shares of common stock at a public offering price of $10.00 per share. The gross proceeds from the offering were $57.5 million before deducting underwriting discounts, commissions and estimated offering expenses. This includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional shares of common stock from the company at the public offering price, less underwriting discounts and commissions. All of the shares of common stock were offered by IDEAYA Biosciences. The shares commenced trading on the Nasdaq Global Select Market on May 23, 2019, under the ticker symbol “IDYA”.

J.P. Morgan, Citigroup and Jefferies acted as joint book-running managers for the offering.

https://www.biospace.com/article/releases/ideaya-biosciences-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/